Structure of the mouse leukaemia inhibitory factor receptor gene:: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5′ untranslated region

被引:20
作者
Chambers, I
Cozens, A
Broadbent, J
Robertson, M
Lee, M
Li, M
Smith, A
机构
[1] Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland
[2] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1042/bj3280879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The low-affinity leukaemia inhibitory factor receptor (LIF-R) is a component of cell-surface receptor complexes for the multifunctional cytokines leukaemia inhibitory factor, ciliary neurotrophic factor, oncostatin M and cardiotrophin-1. Both soluble and transmembrane forms of the protein have been described and several LIF-R mRNAs have been reported previously. In order to determine the coding potential of LIF-R mRNAs we have isolated and characterized the mouse LIF-R gene, mRNA encoding soluble LIF-R (sLIF-R) is formed by inclusion of an exon in which polyadenylation signals are provided by a B2 repeat, This exon is located centrally within the LIF-R gene but is excluded from the transmembrane LIF-R mRNA by alternative splicing, The transmembrane receptor is encoded by 19 exons distributed over 38 kb. Two distinct 5' non-coding exons have been identified, indicating the existence of alternative promoters. One of these is G/C rich and possesses a consensus initiator sequence as well as potential Spl binding sites. Expression of exon 1 from this promoter occurs in a wide variety of tissues, whereas expression of the alternative 5' untranslated region (exon la) is normally restricted to liver, the principal source of sLIF-R. During pregnancy expression of exon la becomes detectable also in the uterus. Expression of exon la increases dramatically during gestation and is accompanied by a similar quantitative rise in expression of sLIF-R mRNA. These findings establish that expression of LIF-R is under complex transcriptional control and indicate that regulated expression of the soluble cytokine receptor isoform may be due principally to an increase in the activity of a dedicated promoter.
引用
收藏
页码:879 / 888
页数:10
相关论文
共 50 条
  • [41] CHOICE OF STATS AND OTHER SUBSTRATES SPECIFIED BY MODULAR TYROSINE-BASED MOTIFS IN CYTOKINE RECEPTORS
    STAHL, N
    FARRUGGELLA, TJ
    BOULTON, TG
    ZHONG, Z
    DARNELL, JE
    YANCOPOULOS, GD
    [J]. SCIENCE, 1995, 267 (5202) : 1349 - 1353
  • [42] BLASTOCYST IMPLANTATION DEPENDS ON MATERNAL EXPRESSION OF LEUKEMIA INHIBITORY FACTOR
    STEWART, CL
    KASPAR, P
    BRUNET, LJ
    BHATT, H
    GADI, I
    KONTGEN, F
    ABBONDANZO, SJ
    [J]. NATURE, 1992, 359 (6390) : 76 - 79
  • [43] PREGNANCY-ASSOCIATED INCREASE IN MESSENGER-RNA FOR SOLUBLE D-FACTOR/LIF RECEPTOR IN MOUSE-LIVER
    TOMIDA, M
    YAMAMOTOYAMAGUCHI, Y
    HOZUMI, M
    [J]. FEBS LETTERS, 1993, 334 (02) : 193 - 197
  • [44] ANALYSIS OF RECOMBINANT SOLUBLE MOUSE D-FACTOR LIF RECEPTOR
    TOMIDA, M
    [J]. JOURNAL OF BIOCHEMISTRY, 1995, 117 (06) : 1228 - 1231
  • [45] TONMIDA M, 1994, J BIOCHEM-TOKYO, V155, P557
  • [46] WARE CB, 1995, DEVELOPMENT, V121, P1283
  • [47] MYELOID-LEUKEMIA INHIBITORY FACTOR MAINTAINS THE DEVELOPMENTAL POTENTIAL OF EMBRYONIC STEM-CELLS
    WILLIAMS, RL
    HILTON, DJ
    PEASE, S
    WILLSON, TA
    STEWART, CL
    GEARING, DP
    WAGNER, EF
    METCALF, D
    NICOLA, NA
    GOUGH, NM
    [J]. NATURE, 1988, 336 (6200) : 684 - 687
  • [48] EVOLUTION OF THE IL-6 CLASS IB CYTOKINE RECEPTOR FAMILY IN THE IMMUNE AND NERVOUS SYSTEMS
    YAMAMORI, T
    SARAI, A
    [J]. JOURNAL OF PHYSIOLOGY-PARIS, 1994, 88 (03) : 165 - 171
  • [49] MAINTENANCE OF THE PLURIPOTENTIAL PHENOTYPE OF EMBRYONIC STEM-CELLS THROUGH DIRECT ACTIVATION OF GP130 SIGNALING PATHWAYS
    YOSHIDA, K
    CHAMBERS, I
    NICHOLS, J
    SMITH, A
    SAITO, M
    YASUKAWA, K
    SHOYAB, M
    TAGA, T
    KISHIMOTO, T
    [J]. MECHANISMS OF DEVELOPMENT, 1994, 45 (02) : 163 - 171
  • [50] Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders
    Yoshida, K
    Taga, T
    Saito, M
    Suematsu, S
    Kumanogoh, A
    Tanaka, T
    Fujiwara, H
    Hirata, M
    Yamagami, T
    Nakahata, T
    Hirabayashi, T
    Yoneda, Y
    Tanaka, K
    Wang, WZ
    Mori, C
    Shiota, K
    Yoshida, N
    Kishimoto, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 407 - 411